KR20040096016A - 신규한 폴리에틸렌글리콜-말레이미드 유도체의 합성방법 - Google Patents
신규한 폴리에틸렌글리콜-말레이미드 유도체의 합성방법 Download PDFInfo
- Publication number
- KR20040096016A KR20040096016A KR1020030028807A KR20030028807A KR20040096016A KR 20040096016 A KR20040096016 A KR 20040096016A KR 1020030028807 A KR1020030028807 A KR 1020030028807A KR 20030028807 A KR20030028807 A KR 20030028807A KR 20040096016 A KR20040096016 A KR 20040096016A
- Authority
- KR
- South Korea
- Prior art keywords
- peg
- arm
- maleimide
- general formula
- polymer compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/12—Unsaturated polyimide precursors
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
- C08G65/33331—Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing imide group
- C08G65/33337—Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing imide group cyclic
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Polyethers (AREA)
- Medicinal Preparation (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Pyrrole Compounds (AREA)
Abstract
Description
Claims (10)
- 하기 일반식 (I)의 mPEG-말레이미드 중합체 화합물을 제조하는 방법에 있어서, 하기 일반식 (I-a)의 mPEG-말레아믹 산 유도체에 펜타플루오로페닐 트리플루오로아세테이트와 같은 반응화제를 염기 및 유기용매 존재 하에 반응시킴으로서 시클릭화를 시켜 일반식 (I) 중합체 화합물을 제조함을 특징으로 하는 제조방법;(Ⅰ)(I-a)
- 하기 일반식 (II)의 PEG-(말레이미드)2중합체 화합물을 제조하는 방법에 있어서, 일반식 (II-a)의 PEG-비스(말레아믹 산)2에 펜타플루오로페닐 트리플루오로아세테이트와 같은 반응화제를 염기 및 유기용매 존재 하에 반응시킴으로서 시클릭화를 시켜 일반식 (II) 중합체 화합물을 제조함을 특징으로 하는 제조방법;(II)(II-a)
- 하기 일반식 (III)의 다중 암 PEG-말레이미드 중합체 화합물을 제조하는 방법에 있어서, 일반식 (III-a)의 다중 암 PEG-말레아믹산에 펜타플루오로페닐 트리플루오로아세테이트와 같은 반응화제를 염기 및 유기용매 존재 하에 반응시킴으로서 시클릭화를 시켜 일반식 (III) 중합체 화합물을 제조함을 특징으로 하는 제조방법;(III)(III-a)상기 식에서 R은 중앙 핵이고;n은 암의 개수로서 3 내지 12인 정수임.
- 하기 일반식 (IV)의 다중 암 펜던트 PEG-말레이미드 중합체 화합물을 제조하는 방법에 있어서, 일반식 (IV-a)의 다중 암 펜던트 PEG-말레아믹 산에 펜타플루오로페닐 트리플루오로아세테이트와 같은 반응화제를 염기 및 유기용매 존재 하에 반응시킴으로서 시클릭화를 시켜 일반식 (IV) 중합체 화합물을 제조함을 특징으로 하는 제조방법;(Ⅳ)(Ⅳ-a)상기의 식에서,R'은 수소 또는 탄소수 1 내지 3의 저급알킬기를 나타내고,n'는 3 내지 12의 정수이고,m은 1 내지 20의 암의 개수를 나타낸다.
- 제 1항 내지 제 4항 중 어느 한 항에 있어서, 반응화제는 펜타플루오로페닐 트리플루오로아세테이트임을 특징으로 하는 제조방법.
- 제 1항 내지 제 4항 중 어느 한 항에 있어서, 염기는 DIEA 또는 DEA인 것임을 특징으로 하는 제조방법.
- 제 1항 내지 제 4항 중 어느 한 항에 있어서, 유기용매는 디클로로메탄 과 DMF의 혼합 용매를 사용함을 특징으로 하는 제조방법.
- 제 7항에 있어서, 유기용매는 디클로로메탄 및 DMF(4:1) 혼합용매를 사용함을 특징으로 하는 제조방법.
- 제 1항 내지 제 4항 중 어느 한 항에 있어서, 일반식 (Ⅰ) 내지 (Ⅳ)의 PEG 중합체는 에틸렌 글리콜을 기본으로 하는 선형 mPEG, 선형 다기능 PEG 등의 선형 PEG, mPEG, 다중-암 PEG, 펜던트 형-다중-암-PEG 수용성 고분자를 포함한 PEG 기본형 중합체인 제조방법.
- 제 1항 내지 제 4항 중 어느 한 항에 있어서, 일반식 (Ⅰ) 내지 (Ⅳ)의 PEG 중합체는 분자량이 100 내지 1,000,000 달톤(D)인 PEG 중합체 제조방법.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2003-0028807A KR100512483B1 (ko) | 2003-05-07 | 2003-05-07 | 신규한 폴리에틸렌글리콜-말레이미드 유도체의 합성방법 |
US10/697,409 US6828401B2 (en) | 2003-05-07 | 2003-10-29 | Preparation method of peg-maleimide derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2003-0028807A KR100512483B1 (ko) | 2003-05-07 | 2003-05-07 | 신규한 폴리에틸렌글리콜-말레이미드 유도체의 합성방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040096016A true KR20040096016A (ko) | 2004-11-16 |
KR100512483B1 KR100512483B1 (ko) | 2005-09-05 |
Family
ID=33411643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2003-0028807A KR100512483B1 (ko) | 2003-05-07 | 2003-05-07 | 신규한 폴리에틸렌글리콜-말레이미드 유도체의 합성방법 |
Country Status (2)
Country | Link |
---|---|
US (1) | US6828401B2 (ko) |
KR (1) | KR100512483B1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009011486A1 (en) * | 2007-07-18 | 2009-01-22 | Id Biochem, Inc. | A new preparing method of methoxypolyethyleneglycol ethylmaleimide |
Families Citing this family (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060104968A1 (en) | 2003-03-05 | 2006-05-18 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases |
US7871607B2 (en) | 2003-03-05 | 2011-01-18 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
ES2335005T5 (es) | 2003-03-05 | 2013-04-17 | Halozyme, Inc. | Glicoproteína hialuronidasa soluble (shasegp), proceso para prepararla, usos y composiciones farmacéuticas que la comprenden |
WO2005056636A2 (en) | 2003-12-03 | 2005-06-23 | Nektar Therapeutics Al, Corporation | Method of preparing maleimide functionalized polymers |
GB0329825D0 (en) * | 2003-12-23 | 2004-01-28 | Celltech R&D Ltd | Biological products |
WO2005115477A2 (en) | 2004-04-13 | 2005-12-08 | Quintessence Biosciences, Inc. | Non-natural ribonuclease conjugates as cytotoxic agents |
EP1796746B1 (en) | 2004-10-07 | 2011-05-04 | E.I. Du Pont De Nemours And Company | Polysaccharide-based polymer tissue adhesive for medical use |
KR101334541B1 (ko) * | 2005-07-19 | 2013-11-28 | 넥타르 테라퓨틱스 | 중합체 말레이미드를 제조하는 방법 |
US7301003B2 (en) * | 2005-08-26 | 2007-11-27 | Enzon Pharmaceuticals, Inc. | Method of preparing polymers having terminal amine groups |
KR100664969B1 (ko) * | 2005-08-26 | 2007-01-04 | 아이디비켐(주) | 고순도의 메톡시폴리에틸렌글리콜 및 그들의 유도체의제조방법 |
US7601798B2 (en) * | 2005-10-04 | 2009-10-13 | Enzon Pharmaceuticals, Inc. | Methods of preparing polymers having terminal amine groups using protected amine salts |
US8133707B2 (en) * | 2006-01-17 | 2012-03-13 | Enzon Pharmaceuticals, Inc. | Methods of preparing activated polymers having alpha nitrogen groups |
EP2001529A4 (en) * | 2006-03-21 | 2011-11-09 | Agency Science Tech & Res | MATERIAL FOR CELLULAR ADHESION POLYELECTROLYTE FOR USE AS MEMBRANE AND COATING |
US7868132B2 (en) | 2006-04-25 | 2011-01-11 | E. I. Du Pont De Nemours And Company | Method for preparing multi-arm poly (ethylene glycol) amines |
US8840882B2 (en) | 2006-06-23 | 2014-09-23 | Quintessence Biosciences, Inc. | Modified ribonucleases |
US7960498B2 (en) | 2006-06-30 | 2011-06-14 | Actamax Surgical Materials, Llc | Tissue adhesives with modified elasticity |
JP2009543868A (ja) | 2006-07-17 | 2009-12-10 | クインテセンス バイオサイエンシーズ インコーポレーティッド | 癌治療に関する方法および組成物 |
CN101541857B (zh) * | 2006-11-27 | 2012-12-12 | 阿克塔马克斯手术器材有限责任公司 | 多官能聚环氧烷、水凝胶和组织粘合剂 |
TWI412591B (zh) * | 2007-04-20 | 2013-10-21 | Sigma Tau Rare Diseases S A | 穩定的重組腺苷脫胺酶 |
US8697062B2 (en) * | 2007-10-08 | 2014-04-15 | Quintessence Biosciences, Inc. | Compositions and methods for ribonuclease-based therapeutics |
US8426492B2 (en) | 2007-11-14 | 2013-04-23 | Actamax Surgical Materials, Llc | Oxidized cationic polysaccharide-based polymer tissue adhesive for medical use |
KR100922113B1 (ko) | 2007-12-29 | 2009-10-16 | 아이디비켐(주) | 고순도의 벤질옥시폴리에틸렌글리콜 및 그의 유도체의제조방법 |
TWI395593B (zh) | 2008-03-06 | 2013-05-11 | Halozyme Inc | 可活化的基質降解酵素之活體內暫時性控制 |
CA2721229C (en) | 2008-04-14 | 2022-08-23 | Halozyme, Inc. | Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions |
TWI394580B (zh) | 2008-04-28 | 2013-05-01 | Halozyme Inc | 超快起作用胰島素組成物 |
US8551136B2 (en) | 2008-07-17 | 2013-10-08 | Actamax Surgical Materials, Llc | High swell, long-lived hydrogel sealant |
JP2012504423A (ja) | 2008-10-01 | 2012-02-23 | クインテッセンス バイオサイエンシズ,インコーポレーテッド | 治療用リボヌクレアーゼ |
US10040838B2 (en) * | 2008-11-04 | 2018-08-07 | Janssen Pharmaceutica Nv | CRHR2 peptide agonists and uses thereof |
US8466327B2 (en) | 2008-11-19 | 2013-06-18 | Actamax Surgical Materials, Llc | Aldehyde-functionalized polyethers and method of making same |
EP2349357B1 (en) * | 2008-11-19 | 2012-10-03 | Actamax Surgical Materials LLC | Hydrogel tissue adhesive formed from aminated polysaccharide and aldehyde-functionalized multi-arm polyether |
EA022752B1 (ru) | 2008-12-09 | 2016-02-29 | Галозим, Инк. | Длинные растворимые полипептиды рн20 и их использование |
EP2406632B1 (en) | 2009-01-30 | 2013-05-29 | Bristol-Myers Squibb Company | Sensitive method to analyse free peg-maleimide |
WO2010118284A1 (en) | 2009-04-09 | 2010-10-14 | E. I. Du Pont De Nemours And Company | Hydrogel tissue adhesive having reduced degradation time |
BRPI1015424B1 (pt) | 2009-06-22 | 2022-01-18 | Burnham Institute For Medical Research | Composição compreendendo um elemento cendr e uma co-composição e composição para uso no reforço da internalização, penetração, ou ambas, de uma co-composição |
WO2011002956A1 (en) | 2009-07-02 | 2011-01-06 | E. I. Du Pont De Nemours And Company | Aldehyde-functionalized polysaccharides |
JP5872463B2 (ja) | 2009-07-02 | 2016-03-01 | アクタマックス サージカル マテリアルズ リミテッド ライアビリティカンパニー | 医療用ヒドロゲル組織接着剤 |
US8796242B2 (en) | 2009-07-02 | 2014-08-05 | Actamax Surgical Materials, Llc | Hydrogel tissue adhesive for medical use |
US8580950B2 (en) | 2009-07-02 | 2013-11-12 | Actamax Surgical Materials, Llc | Aldehyde-functionalized polysaccharides |
JP5734985B2 (ja) | 2009-09-17 | 2015-06-17 | バクスター・ヘルスケヤー・ソシエテ・アノニムBaxter Healthcare SA | ヒアルロニダーゼおよび免疫グロブリンの安定な共製剤およびそれらの使用方法 |
MX2012005262A (es) | 2009-11-04 | 2012-09-28 | Janssen Pharmaceutica Nv | Metodo para tratar la insuficiencia cardiaca con petidos tipo estrescopina. |
RU2016105962A (ru) | 2009-12-04 | 2018-11-23 | Дженентек, Инк. | Мультиспецифические антитела, аналоги антител, композиции и способы |
US8592364B2 (en) * | 2010-02-11 | 2013-11-26 | Ecole Polytechnique Federale de Lausanne (“EPFL”) | CCR7 ligand delivery and co-delivery in immunotherapy |
MX2013000250A (es) | 2010-07-02 | 2013-10-28 | Angiochem Inc | Polipeptidos cortos y que contienen d-aminoacido para conjugados terapeuticos y usos de los mismos. |
DK2595624T3 (en) | 2010-07-20 | 2018-03-26 | Halozyme Inc | Methods of treating or preventing adverse side effects associated with administration of an anti-hyaluronan agent |
JP2014510045A (ja) | 2011-02-08 | 2014-04-24 | ハロザイム インコーポレイテッド | ヒアルロナン分解酵素の組成物および脂質製剤ならびに良性前立腺肥大症の治療のためのその使用 |
WO2012118778A1 (en) | 2011-02-28 | 2012-09-07 | Sanford-Burnham Medical Research Institute | Truncated car peptides and methods and compositions using truncated car peptides |
CA2837588A1 (en) | 2011-05-31 | 2012-12-06 | Airware, Inc. | Re-calibration of ab ndir gas sensors |
US9993529B2 (en) | 2011-06-17 | 2018-06-12 | Halozyme, Inc. | Stable formulations of a hyaluronan-degrading enzyme |
KR101676543B1 (ko) | 2011-06-17 | 2016-11-15 | 할로자임, 아이엔씨 | 히알루로난 분해효소를 이용한 연속적인 피하 인슐린 주입 방법 |
US10179801B2 (en) | 2011-08-26 | 2019-01-15 | Sanford-Burnham Medical Research Institute | Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides |
WO2013040501A1 (en) | 2011-09-16 | 2013-03-21 | Pharmathene, Inc. | Compositions and combinations of organophosphorus bioscavengers and hyaluronan-degrading enzymes, and uses thereof |
EP2771028A2 (en) | 2011-10-24 | 2014-09-03 | Halozyme, Inc. | Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof |
CA2855770A1 (en) | 2011-11-17 | 2013-05-23 | Cebix Ab | Pegylated c-peptide |
DK3130347T3 (da) | 2011-12-30 | 2019-10-14 | Halozyme Inc | PH20-polypeptidvarianter, formuleringer og anvendelser deraf |
WO2013148375A1 (en) | 2012-03-29 | 2013-10-03 | Sangart, Inc. | Diaspirin crosslinked pegylated hemoglobin |
WO2013151776A1 (en) | 2012-04-03 | 2013-10-10 | Sangart, Inc. | Succinimide-activated nitroxyl compounds and methods for the use thereof for nitroxylation of proteins |
AU2013243873B2 (en) | 2012-04-04 | 2016-08-25 | Halozyme, Inc. | Combination therapy with an anti - hyaluronan agent and a tumor - targeted taxane |
WO2014062856A1 (en) | 2012-10-16 | 2014-04-24 | Halozyme, Inc. | Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods |
US8859705B2 (en) | 2012-11-19 | 2014-10-14 | Actamax Surgical Materials Llc | Hydrogel tissue adhesive having decreased gelation time and decreased degradation time |
KR101954257B1 (ko) * | 2013-01-08 | 2019-03-05 | 주식회사 엘지생활건강 | 소수성 표면을 형성하는 반영구 보습 트리트먼트제 |
WO2014145755A1 (en) | 2013-03-15 | 2014-09-18 | Sangart, Inc. | Polyalkylene oxide valerate hemoglobin conjugates |
TW201534726A (zh) | 2013-07-03 | 2015-09-16 | Halozyme Inc | 熱穩定ph20玻尿酸酶變異體及其用途 |
US20160184474A1 (en) | 2013-07-29 | 2016-06-30 | Actamax Surgical Materials, Llc | Low swell tissue adhesive and sealant formulations |
MX2016001854A (es) | 2013-08-12 | 2016-09-06 | Genentech Inc | Composiciones y metodo para tratar condiciones asociadas con el complemento. |
CA2944712A1 (en) | 2014-05-01 | 2015-11-05 | Genentech, Inc. | Anti-factor d antibody variants and uses thereof |
WO2015175774A1 (en) | 2014-05-14 | 2015-11-19 | Trustees Of Dartmouth College | Deimmunized lysostaphin and methods of use |
HUE043847T2 (hu) | 2014-08-28 | 2019-09-30 | Halozyme Inc | Hialuronán-lebontó enzimmel és egy immun checkpoint inhibitorral végzett kombinációs terápia |
DK3207130T3 (da) | 2014-10-14 | 2019-11-11 | Halozyme Inc | Sammensætninger af Adenosin Deaminase-2 (ADA2), varianter deraf og fremgangsmåder til anvendelse af samme |
BR112018002838A2 (pt) | 2015-08-12 | 2019-01-15 | Cell Machines Inc | complexo do fator de coagulação, kit, método de tratamento |
CN108472382A (zh) | 2015-10-30 | 2018-08-31 | 豪夫迈·罗氏有限公司 | 抗-因子d抗体变体缀合物及其用途 |
WO2017075173A2 (en) | 2015-10-30 | 2017-05-04 | Genentech, Inc. | Anti-factor d antibodies and conjugates |
FR3044222B1 (fr) | 2015-11-30 | 2020-01-03 | L'oreal | Procede de traitement cosmetique des matieres keratiniques |
CN107045064A (zh) * | 2017-01-13 | 2017-08-15 | 中国药科大学 | 一种基于衍生化的多肽在血浆样品中的前处理方法 |
KR102675270B1 (ko) | 2017-06-22 | 2024-06-17 | 버텍스 파마슈티칼스 인코포레이티드 | 변형된 막 유형 세린 프로테아제 1(mtsp-1) 폴리펩티드 및 사용 방법 |
WO2019222435A1 (en) | 2018-05-16 | 2019-11-21 | Halozyme, Inc. | Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20 |
CN109575193A (zh) * | 2018-10-29 | 2019-04-05 | 湖南湘江关西涂料有限公司 | 一种丙烯酸酯改性不饱和聚酯乳液及其制备方法 |
US11613744B2 (en) | 2018-12-28 | 2023-03-28 | Vertex Pharmaceuticals Incorporated | Modified urokinase-type plasminogen activator polypeptides and methods of use |
AU2019413431A1 (en) | 2018-12-28 | 2021-07-08 | Vertex Pharmaceuticals Incorporated | Modified urokinase-type plasminogen activator polypeptides and methods of use |
US10882954B2 (en) | 2019-04-11 | 2021-01-05 | Sunbio Inc. | Tertiary alkoxy polyethylene glycol and derivatives thereof |
EP3954393A1 (en) | 2020-08-13 | 2022-02-16 | Bioasis Technologies Inc. | Combination therapies for delivery across the blood brain barrier |
US11952461B2 (en) | 2021-03-22 | 2024-04-09 | Sunbio, Inc. | Siloxy polyethylene glycol and derivatives thereof |
WO2023097213A1 (en) | 2021-11-24 | 2023-06-01 | Pykus Therapeutics, Inc. | Hydrogel formulations and methods and devices for focal administration of the same |
CN114524943B (zh) * | 2022-04-22 | 2022-09-16 | 天津凯莱英制药有限公司 | 聚乙二醇-甘油衍生物及其中间体各自的制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US5166322A (en) * | 1989-04-21 | 1992-11-24 | Genetics Institute | Cysteine added variants of interleukin-3 and chemical modifications thereof |
AU4406793A (en) | 1992-06-04 | 1993-12-30 | Clover Consolidated, Limited | Water-soluble polymeric carriers for drug delivery |
HU226646B1 (en) | 1996-03-12 | 2009-05-28 | Pg Txl Company | Water soluble pharmaceutical compositions containing taxane derivatives |
US7217845B2 (en) * | 2002-11-25 | 2007-05-15 | Sun Bio, Inc. | Bifunctional polyethylene glycol derivatives |
-
2003
- 2003-05-07 KR KR10-2003-0028807A patent/KR100512483B1/ko active IP Right Grant
- 2003-10-29 US US10/697,409 patent/US6828401B2/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009011486A1 (en) * | 2007-07-18 | 2009-01-22 | Id Biochem, Inc. | A new preparing method of methoxypolyethyleneglycol ethylmaleimide |
Also Published As
Publication number | Publication date |
---|---|
KR100512483B1 (ko) | 2005-09-05 |
US20040225097A1 (en) | 2004-11-11 |
US6828401B2 (en) | 2004-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100512483B1 (ko) | 신규한 폴리에틸렌글리콜-말레이미드 유도체의 합성방법 | |
US10385165B2 (en) | N-maleimidyl polymer derivatives | |
ES2404685T3 (es) | Derivados heterobifuncionales de poli(etilenglicol) y métodos para su preparación | |
US6294697B1 (en) | Discrete-length polyethylene glycols | |
EP0824126B2 (en) | Preparation of carboxylic acid-containing polyether and biologically active substances derived thereof | |
JP6051998B2 (ja) | マルチアーム型ポリエチレングリコール誘導体、その中間体及び製造方法 | |
EP1603954A2 (en) | Activated forms of water-soluble polymers | |
US7662908B2 (en) | Process for the preparation of activated polythylene glycols | |
CA2618701A1 (en) | Methods of preparing polymers having terminal amine groups | |
CA2724823C (en) | A method for preparing high-purity polyethyleneglycol aldehyde derivatives | |
ES2363122T3 (es) | Método para modificar un sistema macromolecular. | |
JP2008174755A (ja) | ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法 | |
JP6361083B2 (ja) | ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法 | |
KR100551096B1 (ko) | 신규한 와이-폴리에틸렌글리콜 유도체 및 그의 제조방법 | |
KR100291828B1 (ko) | 폴리에틸렌글리콜-석시니미딜프로피오네이트 | |
JP2012158759A (ja) | ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法 | |
JP2018115338A (ja) | ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120827 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20130808 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20140829 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160825 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20170825 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20180827 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20190827 Year of fee payment: 15 |